DECRYPTION – The use of this protection is on the rise, but that of the condom is falling, and the disease is circulating.
Failing yet to be able to cure the patients contaminated by the HIV, we have more and more diversified means to prevent the disease, more than forty years after the first cases identified in France. Latest, the PrEP (pre-exposure prophylaxis), sometimes referred to as the “anti-AIDS pill”. Authorized for the first time in France in 2016, it is gradually finding its place with more than 42,000 users at the start of 2022. But despite its progress in certain particularly exposed groups, it is slow to influence the dynamics of new cases.
The treatment consists of taking PrEP, which combines two antiretrovirals (Truvada or generics), before a situation where there is a risk of being contaminated, to block the transmission of the virus. The treatment can be taken on an ad hoc basis, or continuously if the lifestyle requires it (partners often changing, sex workers, etc.). The homosexuals men, who are one of the most exposed groups (43% of new cases)…
This article is for subscribers only. You have 80% left to discover.
Pushing back the limits of science is also freedom.
Keep reading your article for €0.99 for the first month
Already subscribed?
Login